StreetAlpha
13F holdings · Q3 2026

Siren, L.L.C.

New York, NY · files as Siren, L.L.C.
Know the moment Siren, L.L.C. filesYou follow Siren, L.L.C. An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 12, 2026Next filing due Feb 15, 2027CIK 2005245

Siren, L.L.C. reported 110 stocks worth $4.2B in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are SRRK (10.7%), KYMR (7.4%) and ERAS (4.6%). Compared with Q2 2026, the fund opened new positions in ADRX, ASND and DMRA, added to ERAS, TNGX and ARWR, trimmed SRRK, KYMR and RVMD and sold out of DFTX, COF and SION.

Latest filing: what Siren, L.L.C. did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
18 new17 added37 trimmed23 sold outBought about $392M · sold about $569M
New 18
See all 18 →
Added 17
See all 17 →
Trimmed 37
See all 37 →
Sold out 23
See all 23 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$4.2B−14.3% vs last quarter
Stocks held11018 new · 23 sold out
Top 5 weight30.9%spread out
Turnover23%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
SRRK
Scholar Rock Hldg Corp
$453M10.7%9.4M−200K (−2%)8 of 8
2
KYMR
Kymera Therapeutics Inc
$311M7.4%2.8M−151K (−5%)8 of 8
3
ERAS
Erasca Inc
$193M4.6%13.2M+1.8M (+16%)8 of 8
4
RVMD
Revolution Medicines Inc
$174M4.1%850K−50K (−6%)8 of 8
5
ONC
Beone Medicines Ltd
$170M4.0%465KNo change8 of 8
6
TNGX
Tango Therapeutics Inc
$169M4.0%6.8M+605K (+10%)8 of 8
7
MANE
Veradermics Inc
$161M3.8%1.3M−331K (−20%)3 of 8
8
ARWR
Arrowhead Pharmaceuticals in
$150M3.5%2.3M+575K (+34%)8 of 8
9
EWTX
Edgewise Therapeutics Inc
$114M2.7%2.8M−380K (−12%)8 of 8
10
RYTM
Rhythm Pharmaceuticals Inc
$103M2.5%1.1M−50K (−4%)7 of 8
🔒 100 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
DFTX
Definium Therapeutics Inc
$66.8M1.4M
CRINETICS PHARMACEUTICALS IN
$53.2M1.4M
COF
Capital One Finl Corp
$34.4M172K
SION
Sionna Therapeutics Inc
$26.9M611K
ORKA
Oruka Therapeutics Inc
$23.8M250K

🔒 Free account: see all 23.

Options

valued at the underlying shares
StockTypeValueSharesChange
MSFT
Microsoft Corp
Call$12.3M24K0

Reported value

last 8 quarters
$2.3BQ4 '24
$1.8BQ1 '25
$1.9BQ2 '25
$2.6BQ3 '25
$3.4BQ4 '25
$3.6BQ1 '26
$4.9BQ2 '26
$4.2BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 12, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Siren, L.L.C. 13F FAQ

What does Siren, L.L.C. own?

Siren, L.L.C. reported 110 stocks worth $4.2B in its 13F filing for Q3 2026, filed Nov 12, 2026. The table above lists every position in the filing (the top 10 without an account).

What did Siren, L.L.C. buy and sell in Q3 2026?

Compared with Q2 2026: 18 new positions, 17 added to, 37 trimmed and 23 sold out. New positions include ADRX, ASND and DMRA. It sold all of DFTX, COF and SION.

When will Siren, L.L.C. file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Siren, L.L.C.'s portfolio worth?

The Q3 2026 filing reports $4.2B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.